FDA-Approved Fecal Microbiota Therapies for C. difficile
A new review highlights FDA-approved fecal microbiota therapies that reduce recurrence of C. difficile infection. The review explores clinic…
GLP-1 is a hormone your gut already makes — and your gut bacteria help trigger it. As GLP-1 drugs reshape medicine, here is the evidence-based map of where the microbiome actually fits, and where the probiotic marketing outruns it.
A new review highlights FDA-approved fecal microbiota therapies that reduce recurrence of C. difficile infection. The review explores clinic…
A new review examines the relationship between gut microbiota and fracture risk, emphasizing the need for targeted interventions to enhance …
A new study explores how labor prior to delivery may influence the incidence of necrotizing enterocolitis in very low birth weight infants.
A new study investigates the causal relationships between gut microbiota, inflammatory factors, and neonatal jaundice using Mendelian Random…
Research using rat models reveals that early-life stress can cause sex-dependent changes in the gut microbiome during adolescence, highlight…
A new study investigates how chenodeoxycholic acid influences tumor immunity through dendritic cells and TGR5 signaling, offering insights i…
A new study suggests that pre-transplant gut microbiome profiles could help predict early acute rejection in kidney transplant recipients, o…
A new review explores the complex ways heavy metals contribute to cancer, highlighting molecular interactions and the role of the gut microb…
A new study investigates the prevalence of multidrug-resistant Klebsiella pneumoniae in the gut microbiota of pediatric COVID-19 patients, h…
The research that mattered, the hype that didn’t, and one idea worth carrying around. No spam, unsubscribe anytime.
A new review highlights FDA-approved fecal microbiota therapies that reduce recurrence of C. difficile infection. The review explores clinic…
In the phase 2 FMT-LUMINate trial, pairing a healthy-donor fecal transplant with checkpoint inhibitors pushed response rates to 80% in lung …
Within five months the agency cleared two first-in-class fecal-microbiota products for recurrent C. difficile — Ferring’s Rebyota and, in a …
A new review examines the relationship between gut microbiota and fracture risk, emphasizing the need for targeted interventions to enhance …
A new study explores how labor prior to delivery may influence the incidence of necrotizing enterocolitis in very low birth weight infants.
A new study investigates the causal relationships between gut microbiota, inflammatory factors, and neonatal jaundice using Mendelian Random…
A new study explores how probiotics may mitigate the impact of chronic hypoxia on the gut-brain axis and neuroinflammation in mice.
Constipation can precede the tremor by a decade, the brain’s rogue protein turns up in the gut wall first, and removing the vagus nerve seem…
The gut–brain axis is real, the mechanisms are plausible, and the marketing has run far ahead of the trials. What the meta-analyses actually…
“Live cultures” is becoming a measurable claim. Inside the industry shift from vague probiotics to defined, characterized strains.
GLP-1 is a hormone your gut already makes — and your gut bacteria help trigger it. As GLP-1 drugs reshape medicine, here is the evidence-bas…
One gut bacterium has become the face of “next-generation” probiotics — a defined, characterized strain with human metabolic data and a tant…
A new study suggests that pre-transplant gut microbiome profiles could help predict early acute rejection in kidney transplant recipients, o…
Two sequencing methods sit behind nearly every gut test on the market, and they don’t read the same book. One tells you roughly who is there…
A 2026 NIST study found direct-to-consumer microbiome tests so inconsistent that the noise between brands rivaled the real biological differ…